Hispanic lung cancer patients have higher survival than non-Hispanic white patients

September 6, 2012

Analysis of non-small cell lung cancer (NSCLC) patient records in the California Cancer Registry (CCR) database during the 20-year period of 1988-2008 indicates that Hispanics/Latinos with NSCLC have a higher overall survival compared to non-Hispanic white patients, according to research presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology. This symposium is sponsored by the American Society of Clinical Oncology (ASCO), the American Society for Radiation Oncology (ASTRO), the International Association for the Study of Lung Cancer (IASLC), and The University of Chicago.

This study evaluated the records of 14,829 Hispanic patients from the CCR from 1988-2008. Foreign-born Hispanics had a 14 percent decreased risk for death compared to U.S.-born , including individual patient factors and clinical factors. Adjustments for neighborhood factors, specifically socioeconomic status and ethnicity, slightly moderated the significant decrease in death risk among foreign-born Hispanics. The data also indicates that foreign-born Hispanics who lived in the least U.S.-assimilated neighborhoods had the better overall survival.

"The results of this study confirm the 'Hispanic paradox' of improved survival rates for Hispanic/Latino NSCLC patients compared to non-Hispanic white patients, despite lower socio-economic status," said lead author Manali Patel, MD, a post-doctoral fellow in the hematology/oncology department at Stanford University in Stanford, Calif. "Social and neighborhood factors, in addition to being foreign-born, appear to be positive contributing factors to incidence and survival that need further study."

Explore further: Being born in another country may protect against stroke for US Hispanics

More information: The abstract, "How Do Social Factors Explain Outcomes in Non-Small Cell Lung Cancer Among Hispanic/Latinos in California?" will be presented during the Poster Discussion at 5:30 p.m., Central time on September 6, 2012.

Related Stories

Being born in another country may protect against stroke for US Hispanics

February 21, 2012
New research finds foreign-born Hispanics now living in the United States appear to be less likely to have a stroke compared to non-Hispanic white people. The research was released today and will be presented at the American ...

Hispanic lung cancer patients tend to live longer than blacks and whites

April 23, 2012
A new analysis has found that Hispanic lung cancer patients seem to live longer than white or black patients. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study suggests that, ...

Brain radiation after lung cancer treatment reduces risk of cancer spreading

September 6, 2012
Stage III non-small cell lung cancer (NSCLC) patients treated with surgery and/or radiation therapy have a significantly reduced risk of developing brain metastases if they also receive prophylactic cranial irradiation (PCI); ...

Stage I NSCLC patients who receive radiation therapy are surviving longer

September 6, 2012
Stage I, non-small cell lung cancer (NSCLC) patients who received radiation therapy have an increased median survival of 21 months compared to 16 months, and the percentage of patients who receive no treatment declined from ...

Death rate higher in minorities with acute leukemia

September 19, 2011
Blacks and Hispanics have fewer cases of acute leukemia compared to whites but they die at a substantially higher rate, according to study results presented at the Fourth AACR Conference on The Science of Cancer Health Disparities, ...

Recommended for you

Clinical trial suggests new cell therapy for relapsed leukemia patients

November 20, 2017
A significant proportion of children and young adults with treatment-resistant B-cell leukemia who participated in a small study achieved remission with the help of a new form of gene therapy, according to researchers at ...

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

Computer program finds new uses for old drugs

November 16, 2017
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, ...

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

November 16, 2017
Researchers at CeMM and the Medical University of Vienna presented a preliminary report in The Lancet Hematology on the clinical impact of an integrated ex vivo approach called pharmacoscopy. The procedures measure single-cell ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.